NM
Navigator Medicines, Inc.
SEC filingBiotechnology · San Mateo, CA
Amount raised$10Msold at filing
Total offering$40M$30M still open
Investors in the raise3count reported to the SEC
FiledSep 25, 2026first sale Sep 18, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
KRISTIE BASIL GREBEExecutive Officer
STEPHEN BASIL THOMASExecutive Officer, Director, Promoter
MATHIAS BASIL VINTHERDirector
SCOTT BASIL FORRESTExecutive Officer
TAUSIF BUTTExecutive Officer, Director, Promoter
KHUREM BASIL FAROOQDirector
WOUTER BASIL JOUSTRADirector
Executive officers, directors and promoters as listed on the Form D.